• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Coexistence of fibromyalgia and post-polio syndrome in persons with prior poliomyelitis in Turkey: the relations with symptoms, polio-related impairments, and quality of life
CONCLUSIONS: FM frequently coexists in PsPP with PPS and may increase the burden of PPS.Implications for RehabilitationFibromyalgia (FM) is commonly seen in patients with post-polio syndrome (PPS).Co-existing FM may increase the burden of PPS, as it is associated with more severe symptoms, more polio-related impairments, and worse quality of life.Recognition, appropriate referral, and successful management of co-existing FM may allow for reduced symptoms or symptom severity and improved quality of life in persons with PPS.PMID:36169616 | DOI:10.1080/09638288.2022.2127931
Source: Disability and Rehabilitation - September 28, 2022 Category: Rehabilitation Authors: Emre Latifoglou Ece Çınar G öksel Tanıgör Arzu Ya ğız On Source Type: research

The treatment of fatigue by non-invasive brain stimulation
Publication date: Available online 11 April 2017 Source:Neurophysiologie Clinique/Clinical Neurophysiology Author(s): Jean-Pascal Lefaucheur, Moussa A. Chalah, Alaa Mhalla, Ulrich Palm, Samar S. Ayache, Veit Mylius The use of non-invasive brain neurostimulation (NIBS) techniques to treat neurological or psychiatric diseases is currently under development. Fatigue is a commonly observed symptom in the field of potentially treatable pathologies by NIBS, yet very little data has been published regarding its treatment. We conducted a review of the literature until the end of February 2017 to analyze all the studies that repo...
Source: Neurophysiologie Clinique - April 12, 2017 Category: Neuroscience Source Type: research

A randomized controlled trial of coenzyme Q10 for fatigue in the late-onset sequelae of poliomyelitis.
CONCLUSION: A daily dose of 100mg coenzyme Q10 for 60 days does not alleviate the fatigue of the late-onset sequelae of poliomyelitis. The registration number for the clinical trial is ACTRN 12612000552886. PMID: 26645517 [PubMed - in process]
Source: Complementary Therapies in Medicine - December 1, 2015 Category: Complementary Medicine Authors: Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W Tags: Complement Ther Med Source Type: research

Immunoglobulin G for the Treatment of Chronic Pain: Report of an Expert Workshop
ConclusionsIgG is a promising treatment in several chronic pain conditions. IgG is a relatively safe therapeutic strategy, with uncommon and mild side effects but high costs. Randomized, controlled trials and predictive tests are needed to better support the use of IgG for refractory chronic pain.
Source: Pain Medicine - January 14, 2014 Category: Anesthesiology Authors: Stefano Tamburin, Kristian Borg, Xavier J. Caro, Stefano Jann, Alexander J. Clark, Francesca Magrinelli, Gen Sobue, Lars Werhagen, Giampietro Zanette, Haruki Koike, Peter J. Späth, Angela Vincent, Andreas Goebel Tags: Review Article Source Type: research